Blackrock, INC Schedule 13G passive stakes
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Independence Realty Trust, Discloses 14.4% Beneficial Ownership
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 14.4% beneficial ownership stake in Independence Realty Trust, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Kite Realty Group Trust, Disclosing 14.4% Beneficial Ownership
BlackRock, Inc. has filed an Amendment No. 6 to its Schedule 13G, revealing a 14.4% beneficial ownership stake in Kite Realty Group Trust as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 16% Passive Stake in American Woodmark Corp
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 16.0% passive beneficial ownership stake in American Woodmark Corp as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.0% Passive Stake in DNOW Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 15.0% beneficial ownership stake in DNOW Inc.'s common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Stake in Protagonist Therapeutics, Disclosing 14.8% Beneficial Ownership
BlackRock, Inc. has filed an amendment to its Schedule 13G, revealing a 14.8% beneficial ownership stake in Protagonist Therapeutics, Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 10.1% beneficial ownership stake in Harmony Biosciences Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.8% Stake in Watts Water Technologies Inc.
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 12.8% beneficial ownership stake in Watts Water Technologies Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 12.0% Stake in SiTime Corporation
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 12.0% in SiTime Corporation's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 5 to its Schedule 13G, reporting a 13.8% beneficial ownership stake in Thryv Holdings, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.4% Stake in Interface Inc. Common Stock
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.4% of Interface Inc.'s Class A Common Stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.1% Stake in John B. Sanfilippo & Son Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a beneficial ownership of 15.1% of the common stock of John B. Sanfilippo & Son Inc., totaling 1,366,496 shares as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a passive beneficial ownership of 13.6% in Zurn Elkay Water Solutions Corp's common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to Schedule 13G, reporting a beneficial ownership of 13.8% of Lemaitre Vascular Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a 4.1% beneficial ownership stake in TPG Inc.'s Class A Stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a passive beneficial ownership of 11.7% of Azenta, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 0.8% of TELUS International (Cda) Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, revealing a 1.5% beneficial ownership stake in Sigma Lithium Corp's common stock.
NYSE
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing a 15.2% beneficial ownership stake in ScanSource, Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 13.7% Stake in Dime Community Bancshares
BlackRock, Inc. has filed an updated Schedule 13G, revealing a beneficial ownership of 13.7% of Dime Community Bancshares, Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an Amendment No. 16 to its Schedule 13G, revealing a 15.1% beneficial ownership stake in PRA Group Inc. common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 10.4% passive beneficial ownership stake in Monarch Casino & Resort Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.8% passive beneficial ownership stake in Newell Brands Inc. as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.0% beneficial ownership stake in Commvault Systems Inc. common stock as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Amends Petrobras Preferred Stock Stake to 5.5%
BlackRock, Inc. has filed an Amendment No. 4 to its Schedule 13G, disclosing a 5.5% beneficial ownership stake in the Preferred Stock of Petrobras Petroleo Brasileiro SA as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 13.2% beneficial ownership stake in Cinemark Holdings, Inc. as of March 31, 2025, affirming its passive investment intent.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.2% Stake in Tandem Diabetes Care Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a significant beneficial ownership of 15.2% in Tandem Diabetes Care Inc. as of March 31, 2025.
NYSE
SCHEDULE 13G/A: BlackRock Discloses 15.5% Stake in Core Laboratories Inc.
BlackRock, Inc. has filed an amended Schedule 13G, revealing a significant 15.5% beneficial ownership stake in Core Laboratories Inc. /DE/ as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, disclosing a beneficial ownership of 12.1% in DXP Enterprises Inc.'s common stock as of March 31, 2025.
NYSE
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 3.5% beneficial ownership stake in NextDecade Corp. as of March 31, 2025, held for ordinary course investment purposes.
NYSE
BlackRock, Inc. has filed an Amendment No. 2 to its Schedule 13G, disclosing a passive beneficial ownership of 3.9% in IRADIMED CORP's common stock as of March 31, 2025.